Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Catalent Pharma Solutions | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Catalent Pharma Solutions

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Catalent Pharma Solutions

4Q Revenues: $451.3 million (+5%)

4Q Loss: $168.7 million (earnings were $27.6 million 4Q2006)

FY Revenues: $1.7 billion (+6%)

FY Loss: $127.3 million (earnings were $51 million FY2006)

Comments: FY and 4Q revenue growth was primarily driven by the Packaging Services segment, particularly within Europe, as well as from continued strong demand for Zydis products within the Oral Technologies segment. Packaging Services revenue was $138 million in the quarter, up 11% and for the year was $552 million, up 14%. In April 2007, an affiliate of The Blackstone Group acquired the company from Cardinal Health for approximately $3.3 billion.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters